Related Experiment Video
Updated: Nov 30, 2025
MRI and PET in Mouse Models of Myocardial Infarction
Published on: December 19, 2013
Comparative Assessment of Revascularization Versus Drug Management in Coronary Artery Disease (CAD) Associated with
Insights
Coronary revascularization significantly improves heart failure symptoms in patients with viable myocardium after myocardial infarction. Medical management alone did not show significant improvement and led to worsening symptoms over time.
Area of Science:
- Cardiology
- Nuclear Cardiology
- Cardiovascular Imaging
Background:
- Left Ventricular (LV) function and myocardial viability are critical prognostic indicators post-myocardial infarction.
- Ischemic cardiomyopathy management strategies include revascularization and medical therapy.
Purpose of the Study:
- To evaluate the impact of revascularization versus medical management on heart failure symptoms in patients with ischemic cardiomyopathy.
- To assess the role of myocardial viability imaging in predicting outcomes.
Main Methods:
- A study involving 72 patients with ischemic cardiomyopathy, divided into revascularization and medical management groups.
- Advanced imaging techniques, including FDG PET and SPECT MPI, were used for follow-up over 12 months.
Main Results:
- Revascularization led to significant improvement in NYHA functional class (from 2.9 to 2.0) in patients with viable myocardium.
- Medical management showed no significant change in functional class at 6 months and a significant decline by 12 months.
Conclusions:
- Coronary revascularization demonstrates a protective effect in patients with ischemic cardiomyopathy and viable myocardium.
- 18F-FDG PET and SPECT MPI are valuable tools for assessing myocardial viability and guiding treatment decisions.
Aim Of The Study:
Left Ventricular (LV) function and myocardial viability is the key predictor of prognosis after myocardial infarction. Management of ischemic cardiomyopathy (revascularization and or drugs alone) is the objective of this study.
Methodology:
72 patients were assigned to revascularization and medical management group based on the inclusion criteria Follow up was done upto 12 months with advanced imaging techniques (FDG PET and SPECT MPI analyses).
Results:
Subjects with significant viable myocardium, revascularization resulted in significant improvement in heart failure symptoms. The mean NYHA functional class improved from 2.9 ± 0.3 to 2.3 ± 0.5(mean ± SD) after 6 months of revascularization (p < 0.01). This improvement in functional class was maintained after 12 months of revascularization (2.0 ± 0.4 (mean ± SD). Subjects on medical management with a baseline NYHA functional class 2.7 ± 0.5, at 6 months of follow, there was no significant change in functional class (2.8 ± 0.3) (p<0.24). However at 12 months follow up functional class had dropped to 3.0 + 0.3, which was significant as compared to baseline (p <0.03).
Conclusion:
coronary revascularization has a protective effect on patients with ischemic coronary who have viable myocardium and reversible myocardial ischemia as assessed by 18F-FDG PET and SPECT MPI Imaging.
Related Concept Videos
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...